Journal of gynecologic oncology

J Gynecol Oncol · ISSN (e) 2005-0399 · 89 papers in corpus
diagnostic-accuracy 2018
doi:10.3802/jgo.2018.29.e17 ·PMID:29185275

OBJECTIVE: We hypothesized that DNA methylation of development-related genes may occur in endometrial cancer (EC)/ovarian cancer (OC) and may be detected in cervical scrapings. METHODS: We tested methylation status by quantitative methylat…

observational 2017
doi:10.3802/jgo.2018.29.e18 ·PMID:29400011

OBJECTIVE: The aim of this investigation is to compare outcomes of patients according to the presence of cancer arising from endometriosis in ovarian clear cell carcinoma (CCC) and endometrioid carcinoma (EC). METHODS: This study retrospec…

review 2017
doi:10.3802/jgo.2017.28.e32 ·PMID:28198168

Cervical, endometrial, and ovarian cancers, have both high morbidity and mortality among the gynecologic malignant tumors in Japan. The present study was conducted using both the population-based cancer registry and the gynecologic cancer r…

observational 2017
doi:10.3802/jgo.2017.28.e35 ·PMID:28382798

OBJECTIVE: To evaluate if uterine myoma is associated with breast cancer. METHODS: This case-control study used a nationwide database in Taiwan. We identified 24,315 patients with newly diagnosed breast cancer as cases and matched them wit…

review 2017
doi:10.3802/jgo.2017.28.e45 ·PMID:28382802

In 2016, 13 topics were selected as major research advances in gynecologic oncology. For ovarian cancer, study results supporting previous ones regarding surgical preventive strategies were reported. There were several targeted agents that …

review 2017
doi:10.3802/jgo.2017.28.e69 ·PMID:28657230

OBJECTIVE: The malignant transformation (MT) of ovarian mature cystic teratoma (MCT) to squamous cell carcinoma (SCC) is very rare. This study analyzed cases from multiple medical centers in Taiwan to investigate the clinicopathologic chara…

other 2017
doi:10.3802/jgo.2017.28.e40 ·PMID:28541632

OBJECTIVE: Ovarian needle aspiration and biopsy (ONAB) may be employed for pretreatment diagnosis of ovarian malignancies or intraoperatively to facilitate removal of ovarian masses. However, there is reluctance to utilize this procedure du…

review 2017
doi:10.3802/jgo.2017.28.e54 ·PMID:28541641

There has been significant progress in the understanding of the pathology and molecular biology of rare ovarian cancers, which has helped both diagnosis and treatment. This paper provides an update on recent advances in the knowledge and tr…

observational 2016
doi:10.3802/jgo.2016.27.e2 ·PMID:26463431

OBJECTIVE: This study was conducted using the human papillomavirus (HPV) DNA chip test (HDC), in order to determine whether the HPV genotype is a predictor of residual disease in a subsequent hysterectomy following a loop electrosurgical ex…

review 2016
doi:10.3802/jgo.2016.27.e31 ·PMID:27029752

Clear cell carcinoma (CCC) of the ovary is known to show poorer sensitivity to chemotherapeutic agents and to be associated with a worse prognosis than the more common serous adenocarcinoma or endometrioid adenocarcinoma. To improve the sur…

rct 2016
doi:10.3802/jgo.2016.27.e25 ·PMID:27029746

OBJECTIVE: To investigate the role of previous gynecologic surgery, hormone use, and use of non-steroidal anti-inflammatory drugs on the risk of type 1 and type 2 ovarian cancer. METHODS: We utilized data collected for the Prostate, Lung, …

observational 2016
doi:10.3802/jgo.2016.27.e5 ·PMID:26463436

OBJECTIVE: To investigate trends in the incidence of epithelial ovarian cancer (EOC), according to histologic subtypes, in Korean women between 1999 and 2012. METHODS: Data from the Korea Central Cancer Registry recorded between 1999 and 2…

other 2016
doi:10.3802/jgo.2016.27.e36 ·PMID:27102245
review 2016
doi:10.3802/jgo.2016.27.e8 ·PMID:26463434

Endometrial hyperplasia (EH) comprises a spectrum of changes in the endometrium ranging from a slightly disordered pattern that exaggerates the alterations seen in the late proliferative phase of the menstrual cycle to irregular, hyperchrom…

diagnostic-accuracy 2015
doi:10.3802/jgo.2015.26.1.46 ·PMID:25310857

OBJECTIVE: The purpose of this study was to develop a risk prediction score for distinguishing benign ovarian mass from malignant tumors using CA-125, human epididymis protein 4 (HE4), ultrasound findings, and menopausal status. The risk pr…

case-report 2015
doi:10.3802/jgo.2015.26.1.62 ·PMID:25609162

OBJECTIVE: To discuss the feasibility of single-site robotic surgery for benign gynecologic tumors and early stage gynecologic cancers. METHODS: In this single institution, prospective analysis, we analyzed six patients who had undergone s…

case-report 2015
doi:10.3802/jgo.2015.26.2.168 ·PMID:25872897

A new generation of three dimensional (3D) imaging software for the anatomical rendering of the human body, and related surgical pathologies, is postulated. Its practical application is underlined.

observational 2014
doi:10.3802/jgo.2014.25.1.58 ·PMID:24459582

OBJECTIVE: Loss of ARID1A is related to oncogenic transformation of ovarian clear cell adenocarcinoma. The present study was conducted in epithelial ovarian cancer of all tissue types to investigate whether an increased or decreased express…

other 2014
doi:10.3802/jgo.2014.25.4.301 ·PMID:25142623

OBJECTIVE: According to the International Federation of Gynecology and Obstetrics staging, some surgeons perform lymphadenectomy in all patients with early stage endometrial cancer to enable the accurate staging. However, there are some ris…

other 2014
doi:10.3802/jgo.2014.25.4.267 ·PMID:25310031
review 2013
doi:10.3802/jgo.2013.24.1.83 ·PMID:23346317

The standard treatment of advanced ovarian cancer is rapidly changing. As we begin to understand that epithelial ovarian cancer is a heterogeneous disease, our treatment strategies are evolving to include novel biologic drugs that specifica…

observational 2013
doi:10.3802/jgo.2013.24.2.114 ·PMID:23653827

OBJECTIVE: Extrauterine involvement of endometrial carcinoma has a significant effect on the patients' prognosis and treatment decision. In classical method, macroscopic section is taken from the fallopian tube sparing the fimbrial ends. Fi…

review 2013
doi:10.3802/jgo.2013.24.4.376 ·PMID:24167674

One of the exciting findings in recent cancer genome studies is the discovery of somatic mutations in several chromatin remodeling genes. These studies not only illuminate the emerging roles of chromatin remodeling in the pathogenesis of hu…

observational 2013
doi:10.3802/jgo.2013.24.4.342 ·PMID:24167670

OBJECTIVE: To investigate the changes of incidence and prognosis of epithelial ovarian cancer in thirty years in Taiwan. METHODS: The databases of women with epithelial ovarian cancer during the period from 1979 to 2008 were retrieved from…

review 2012
doi:10.3802/jgo.2012.23.1.53 ·PMID:22355468

The annual review of 2011 comprised 11 themes of major research achievements in gynecologic oncology including breast cancer. A potential paradigm shift in the management of ovarian cancer was reviewed through comprehensive genomic analyses…